These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23052410)

  • 1. Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations.
    James LP; Chiew A; Abdel-Rahman SM; Letzig L; Graudins A; Day P; Roberts D
    Eur J Clin Pharmacol; 2013 Apr; 69(4):851-7. PubMed ID: 23052410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure.
    James LP; Letzig L; Simpson PM; Capparelli E; Roberts DW; Hinson JA; Davern TJ; Lee WM
    Drug Metab Dispos; 2009 Aug; 37(8):1779-84. PubMed ID: 19439490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.
    Yue Y; Liu DJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):87-94. PubMed ID: 28816033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing.
    Heard K; Green JL; Anderson V; Bucher-Bartelson B; Dart RC
    Br J Clin Pharmacol; 2016 Mar; 81(3):562-8. PubMed ID: 26584404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
    Franke RM; Morton T; Devarakonda K
    Drug Des Devel Ther; 2015; 9():4587-97. PubMed ID: 26316698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Evaluation of N-Acetyl-p-Benzoquinone Imine Protein Adduct Formation with Therapeutic Acetaminophen Administration: Sex-based Physiologic Differences.
    Arnold CG; Dylla L; Monte AA; Heard K; Heard S; D'Alessandro A; Reynolds K; Dart R; Rumack B; Sonn B
    J Med Toxicol; 2022 Oct; 18(4):297-310. PubMed ID: 35751009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
    Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
    BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried blood microsamples: Suitable as an alternative matrix for the quantification of paracetamol-protein adducts?
    Delahaye L; Dhont E; De Cock P; De Paepe P; Stove CP
    Toxicol Lett; 2020 May; 324():65-74. PubMed ID: 32035980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
    Heard KJ; Green JL; James LP; Judge BS; Zolot L; Rhyee S; Dart RC
    BMC Gastroenterol; 2011 Mar; 11():20. PubMed ID: 21401949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer biphasic IR/ER combination formulation, under fed and fasted conditions.
    Devarakonda K; Morton T; Margulis R; Giuliani M; Barrett T
    Drug Des Devel Ther; 2014; 8():1125-34. PubMed ID: 25170252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Acetaminophen-Protein Adduct Elimination During Renal Failure, Lack of Adduct Removal by Hemodiafiltration, and Urinary Adduct Concentrations After Acetaminophen Overdose.
    Curry SC; Padilla-Jones A; O'Connor AD; Ruha AM; Bikin DS; Wilkins DG; Rollins DE; Slawson MH; Gerkin RD;
    J Med Toxicol; 2015 Jun; 11(2):169-78. PubMed ID: 25288219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations.
    Spyker DA; Dart RC; Yip L; Reynolds K; Brittain S; Yarema M
    Clin Toxicol (Phila); 2022 Oct; 60(10):1113-1121. PubMed ID: 36106921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Derived Acetaminophen-Cysteine Can Be Detected After Repeated Supratherapeutic Ingestion of Acetaminophen in the Absence of Hepatotoxicity.
    O'Malley GF; Mizrahi F; Giraldo P; O'Malley RN; Rollins D; Wilkins D
    J Med Toxicol; 2015 Sep; 11(3):317-20. PubMed ID: 26002216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids.
    Devarakonda K; Kostenbader K; Zheng Y; Montgomery JB; Barrett T; Young JL; Webster LR
    Postgrad Med; 2015 Jan; 127(1):13-21. PubMed ID: 25584931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
    Darwish M; Bond M; Tracewell W; Robertson P; Yang R
    Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaminophen Adducts Detected in Serum of Pediatric Patients With Acute Liver Failure.
    Alonso EM; James LP; Zhang S; Squires RH;
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):102-7. PubMed ID: 25859823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells.
    Xie Y; McGill MR; Cook SF; Sharpe MR; Winefield RD; Wilkins DG; Rollins DE; Jaeschke H
    Xenobiotica; 2015; 45(10):921-9. PubMed ID: 25869248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirming the Causative Role of Acetaminophen in Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine Adducts.
    Frey SM; Wiegand TJ; Green JL; Heard KJ; Wilkins DG; Gorodetsky RM; Dart RC
    J Med Toxicol; 2015 Jun; 11(2):218-22. PubMed ID: 25896948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trial.
    Morton T; Kostenbader K; Montgomery J; Devarakonda K; Barrett T; Webster L
    Postgrad Med; 2014 Jul; 126(4):20-32. PubMed ID: 25141240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.